Cysteinylation and homocysteinylation of plasma protein thiols during ageing of healthy human beings

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 3131-3140

  Rossi, R ^a   Giustarini, D ^a   Milzani, A ^b   Dalle Donne, I ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Ageing; Biomarkers of oxidative stress; Plasma antioxidant capacity; Protein thiols; S thiolated proteins

Indexed keywords

ANTIOXIDANT; CYSTEINE; HOMOCYSTEINE; THIOL DERIVATIVE;

ADULT; AGED; AGING; ARTICLE; CHEMISTRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; OXIDATIVE STRESS; RISK;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIOXIDANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; RISK; SULFHYDRYL COMPOUNDS;

EID: 77449142984     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00417.x     Document Type: Article

References (65)

1. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev. 1998, 78:547-81.
2. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000, 408:239-47.
3. Lenton KJ, Therriault H, Cantin AM. Direct correlation of glutathione and ascorbate and their dependence on age and season in human lymphocytes. Am J Clin Nutr. 2000, 71:1194-200.
4. Mecocci P, Polidori MC, Troiano L. Plasma antioxidants and longevity: a study on healthy centenarians. Free Radic Biol Med. 2000, 28:1243-8.
5. Macmillan-Crow LA, Cruthirds DL. Manganese superoxide dismutase in disease. Free Radic Res. 2001, 34:325-36.
6. Jones DP, Mody VC, Carlson JL. Redox analysis of human plasma allows separation of prooxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med. 2002, 33:1290-300.
7. Himmelfarb J, Hakim RM. Oxidative stress in uremia. Curr Opin Nephrol Hypertens. 2003, 12:593-8.
8. Moriarty SE, Shah JH, Lynn M. Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic Biol Med. 2003, 35:1582-8.
9. Go YM, Jones DP. Intracellular proatherogenic events and cell adhesion modulated by extracellular thiol/disulfide redox state. Circulation. 2005, 111:2973-80.
10. Ashfaq S, Abramson JL, Jones DP. The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol. 2006, 47:1005-11.
11. Aslam S, Santha T, Leone A. Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis. Kidney Int. 2006, 70:2109-15.
12. Zinellu A, Zinellu E, Sotgia S. Factors affecting S-homocysteinylation of LDL apoprotein B. Clin Chem. 2006, 52:2054-9.
13. Ogasawara Y, Mukai Y, Togawa T. Determination of plasma thiol bound to albumin using affinity chromatography and high-performance liquid chromatography with fluorescence detection: ratio of cysteinyl albumin as a possible biomarker of oxidative stress. J Chromatogr B Analyt Technol Biomed Life Sci. 2007, 845:157-63.
14. Ducros V, Demuth K, Sauvant MP. Methods for homocysteine analysis and biological relevance of the results. J Chromatogr B Analyt Technol Biomed Life Sci. 2002, 781:207-26.
15. Ozkan Y, Ozkan E, Simsek B. Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int J Cardiol. 2002, 82:269-77.
16. Pastore A, Federici G, Bertini E. Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta. 2003, 333:19-39.
17. Zinellu A, Pinna A, Zinellu E. High-throughput capillary electrophoresis method for plasma cysteinylglycine measurement: evidences for a clinical application. Amino Acids. 2008, 34:69-74.
18. Andriollo-Sanchez M, Hininger-Favier I, Meunier N. Age-related oxidative stress and antioxidant parameters in middle-aged and older European subjects: the ZENITH study. Eur J Clin Nutr. 2005, 59:S58-62.
19. Giustarini D, Dalle-Donne I, Lorenzini S. Age-related influence on thiol, disulphide and protein mixed disulphide levels in human plasma. J Gerontol A. 2006, 61:1030-8.
20. Mansoor MA, Svardal AM, Ueland PM. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem. 1992, 200:218-29.
21. Dalle-Donne I, Scaloni A, Giustarini D. Proteins as biomarkers of oxidative/nitrosative stress in diseases. The contribution of redox proteomics. Mass Spectrom Rev. 2005, 24:55-99.
22. Dalle-Donne I, Giustarini D, Colombo R. S-glutathionylation in human platelets by a thiol-disulphide exchange-independent mechanism. Free Radic Biol Med. 2005, 38:1501-10.
23. Dalle-Donne I, Rossi R, Colombo R. Biomarkers of oxidative damage in human disease. Clin Chem. 2006, 52:601-23.
24. Eaton P. Protein thiol oxidation in health and disease: techniques for measuring disulphides and related modifications in complex protein mixtures. Free Radic Biol Med. 2006, 40:1889-99.
25. Hortin GL, Seam N, Hoehn GT. Bound homocysteine, cysteine, and cysteinylglycine distribution between albumin and globulins. Clin Chem. 2006, 52:2258-64.
26. Dalle-Donne I, Milzani A, Gagliano N. Molecular mechanisms and potential clinical significance of S-glutathionylation. Antioxid Redox Signal. 2008, 10:446-73.
27. Dalle-Donne I, Rossi R, Giustarini D. S-Glutathionylation in protein redox regulation. Free Radic Biol Med. 2007, 43:883-98.
28. Samiec PS, Drews-Botsch C, Flagg EW. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med. 1998, 24:699-704.
29. Jones DP, Carlson JL, Mody VC. Redox state of glutathione in human plasma. Free Radic Biol Med. 2000, 28:625-35.
30. Erden-Inal M, Sunal E, Kanbak G. Age-related changes in the glutathione redox system. Cell Biochem Funct. 2002, 20:61-6.
31. Junqueira VB, Barros SB, Chan SS. Aging and oxidative stress. Mol Aspects Med. 2004, 25:5-16.
32. Gil L, Siems W, Mazurek B. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic Res. 2006, 40:495-505.
33. Undas A, Perla J, Lacinski M. Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosis. Stroke. 2004, 35:1299-304.
34. Perna AF, Satta E, Acanfora F. Increased plasma protein homocysteinylation in hemodialysis patients. Kidney Int. 2006, 69:869-76.
35. Rossi R, Dalle-Donne I, Milzani A. Hematic oxidized forms of glutathione: a powerful biomarker of oxidative stress status. Clin Chem. 2006, 52:1406-14.
36. Giustarini D, Dalle-Donne I, Colombo R. An improved HPLC mesurement for GSH and GSSG in human blood. Free Radic Biol Med. 2003, 35:1365-72.
37. Ellman GL. Tissue sulfhydryl goups. Arch Biochem Biophys. 1959, 82:70-7.
38. Jones DP, Carlson JL, Samiec PS. Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin Chim Acta. 1998, 275:175-84.
39. Giustarini D, Dalle-Donne I, Colombo R. Interference of plasmatic glutathione and hemolysis on glutathione disulphide levels in human blood. Free Radic Res. 2004, 38:1101-6.
40. Tsikas D. Incorrect and inconsistent use of homocysteine's nomenclature: a potential source of misunderstandings. Eur J Clin Invest. 2003, 33:1095-6.
41. Jones DP. Redefining oxidative stress. Antioxid Redox Signal. 2006, 8:1865-79.
42. Hildebrandt W, Kinscherf R, Hauer K. Plasma cysteine concentration and redox state in ageing and physical exercise. Mech Ageing Dev. 2002, 123:1269-81.
43. Moriarty-Craige SE, Jones DP. Extracellular thiols and thiol/disulphide redox in metabolism. Annu Rev Nutr. 2004, 24:481-509.
44. Niwa T, Naito C, Mawjood AH. Increased glutathionyl hemoglobin in diabetes mellitus and hyperlipidemia demonstrated by liquid chromatography/electrospray ionization-mass spectrometry. Clin Chem. 2000, 46:82-8.
45. Giustarini D, Dalle-Donne I, Colombo R. Protein glutathionylation in erythrocytes. Clin Chem. 2003, 49:327-30.
46. Mawatari S, Murakami K. Different types of glutathionylation of hemoglobin can exist in intact erythrocytes. Arch Biochem Biophys. 2004, 421:108-14.
47. Sampathkumar R, Balasubramanyam M, Sudarslal S. Increased glutathionylated hemoglobin (HbSSG) in type 2 diabetes subjects with microangiopathy. Clin Biochem. 2005, 38:892-9.
48. Bar-Or D, Curtis CG, Sullivan A. Plasma albumin cysteinylation is regulated by cystathionine beta-synthase. Biochem Biophys Res Commun. 2004, 325:1449-53.
49. Halliwell B, Gutteridge MC. The antioxidants of human extracellular fluids. Arch Biochem Biophys. 1990, 280:1-8.
50. Carballal S, Radi R, Kirk MC. Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry 2003, 42:9906-14.
51. Carballal S, Alvarez B, Turell L. Sulfenic acid in human serum albumin. Amino Acids 2007, 32:543-51.
52. Era S, Kuwata K, Imai H. Age-related change in redox state of human serum albumin. Biochim Biophys Acta. 1995, 1247:12-6.
53. Anderson CL, Iyer SS, Ziegler TR. Control of extracellular cysteine/cystine redox state by HT-29 cells is independent of cellular glutathione. Am J Physiol Regul Integr Comp Physiol. 2007, 293:R1069-75.
54. Ramirez A, Ramadan B, Ritzenthaler JD. Extracellular cysteine/cystine redox potential controls lung fibroblast proliferation and matrix expression through upregulation of transforming growth factor-beta. Am J Physiol Lung Cell Mol Physiol. 2007, 293:L972-81.
55. Refsum H, Helland S, Ueland PM. Radioenzymic determination of homocysteine in plasma and urine. Clin Chem. 1985, 31:624-8.
56. Refsum H, Smith AD, Ueland PM. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem. 2004, 50:3-32.
57. Glushchenko AV, Jacobsen DW. Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease. Antioxid Redox Signal. 2007, 9:1883-98.
58. Giles WH, Croft JB, Greenlund KJ. Association between total homocyst(e)ine and the likelihood for a history of acute myocardial infarction by race and ethnicity: results from the Third National Health and Nutrition Examination Survey. Am Heart J. 2000, 139:446-53.
59. Majors AK, Sengupta S, Willard B. Homocysteine binds to human plasma fibronectin and inhibits its interaction with fibrin. Arterioscler Thromb Vasc Biol. 2002, 22:1354-9.
60. Undas A, Williams EB, Butenas S. Homocysteine inhibits inactivation of factor Va by activated protein C. J Biol Chem. 2001, 276:4389-97.
61. Lim A, Sengupta S, McComb ME. In vitro and in vivo interactions of homocysteine with human plasma transthyretin. J Biol Chem. 2003, 278:49707-13.
62. Ferretti G, Bacchetti T, Moroni C. Effect of homocysteinylation of low density lipoproteins on lipid peroxidation of human endothelial cells. J Cell Biochem. 2004, 92:351-60.
63. Barbato JC, Catanescu O, Murray K. Targeting of metallothionein by L-homocysteine: a novel mechanism for disruption of zinc and redox homeostasis. Arterioscler Thromb Vasc Biol. 2007, 27:49-54.
64. Dröge W, Schipper HM. Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell. 2007, 6:361-70.
65. Ueland PM, Mansoor MA, Guttorsmen AB. Reduced, oxidized and proteinbound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status - a possible element of the extracellular antioxidant defense system. J Nutr 126:1281S-4S.